3 results
10-K/A
2023 FY
ELYM
Eliem Therapeutics Inc
29 Apr 24
Annual report (amended)
4:02pm
The chairperson and members of the following three committees of our Board of Directors are entitled to the following additional annual cash retainers:
Board Committee | Chairperson Fee | Member Fee | ||||||
Audit Committee | $ | 15,000 | $ | 7,500 | ||||
Compensation Committee | 10,000 | 5,000 | ||||||
Nominating and Corporate Governance Committee | 8,000 | 4,000 |
10-K/A
2023 FY
ELYM
Eliem Therapeutics Inc
29 Apr 24
Annual report (amended)
4:02pm
The following table represents aggregate fees billed to the Company for the years ended December 31, 2022 and December 31, 2023 by PricewaterhouseCoopers LLP, Seattle, WA (PCAOB ID 238) the Company’s principal accountant.
Year Ended | ||||||||
2022 | 2023 | |||||||
Audit Fees (1) | $ | 929,500 | $ | 680,000 | ||||
Audit-related Fees | — | — | ||||||
Tax Fees | — | — | ||||||
All Other Fees (2) | $ | 6,650 | $ | 1,944 | ||||
Total Fees | $ | 936,150 | $ | 681,944 |
10-K/A
2023 FY
ELYM
Eliem Therapeutics Inc
29 Apr 24
Annual report (amended)
4:02pm
The Board of Directors has three permanent committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for 2023 for each of these committees:
Name | Audit | Compensation | Nominating and Corporate Governance | ||||||||||||||||||||
Andrew Levin, M.D., Ph.D. | Judith Dunn, Ph.D. | X | X | Liam Ratcliffe, M.D., Ph.D. | X | * | X | * | |||||||||||||||
Adam Rosenberg | X | * | X | Simon Tate | X | X | |||||||||||||||||
Total meetings in 2023 | 4 | 0 | 0 |
- Prev
- 1
- Next